CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- 8-K/A Event Material agreement · Unregistered share sale · Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Delisting notice · Unregistered share sale · Bylaws or fiscal year change
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change
- 8-K Event Unregistered share sale
- 8-K Event Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Unregistered share sale
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
Page 1 of 5 · 94 filings